Sonoma Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.19 Insider Own0.26% Shs Outstand3.11M Perf Week1.92%
Market Cap5.03M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.09M Perf Month-9.40%
Income-6.80M PEG- EPS next Q- Inst Own5.80% Short Float / Ratio4.79% / 0.07 Perf Quarter4.95%
Sales12.60M P/S0.40 EPS this Y17.10% Inst Trans-2.13% Short Interest0.15M Perf Half Y-51.15%
Book/sh1.79 P/B0.59 EPS next Y- ROA-41.80% Target Price- Perf Year-68.45%
Cash/sh0.55 P/C1.94 EPS next 5Y- ROE-92.90% 52W Range0.90 - 4.25 Perf YTD-5.36%
Dividend- P/FCF- EPS past 5Y36.40% ROI-50.90% 52W High-75.06% Beta1.20
Dividend %- Quick Ratio2.10 Sales past 5Y-0.30% Gross Margin31.20% 52W Low17.78% ATR0.12
Employees12 Current Ratio2.90 Sales Q/Q0.00% Oper. Margin-46.30% RSI (14)45.96 Volatility15.21% 10.66%
OptionableNo Debt/Eq0.00 EPS Q/Q-103.60% Profit Margin-54.10% Rel Volume0.08 Prev Close0.94
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume2.05M Price1.06
Recom2.00 SMA201.40% SMA50-19.45% SMA200-49.10% Volume165,310 Change12.44%
Mar-28-23 04:15PM
Mar-02-23 07:30AM
Feb-14-23 04:30PM
Jan-31-23 07:30AM
Jan-25-23 07:30AM
07:30AM Loading…
Jan-04-23 07:30AM
Nov-17-22 05:33AM
Nov-14-22 04:15PM
Oct-27-22 04:01PM
Oct-06-22 04:15PM
Aug-11-22 04:30PM
Aug-02-22 04:30PM
Jul-13-22 04:45PM
Jun-01-22 06:00AM
May-03-22 06:00AM
11:20AM Loading…
Mar-30-22 11:20AM
Feb-11-22 04:30PM
Jan-28-22 09:38AM
Jan-20-22 04:40PM
Jan-05-22 04:55PM
Nov-15-21 08:00AM
Nov-09-21 07:00AM
Oct-15-21 07:44AM
Sep-30-21 12:50PM
Sep-29-21 03:37AM
Sep-28-21 02:37PM
12:19PM Loading…
Aug-20-21 12:19PM
Aug-19-21 01:19PM
Aug-16-21 04:15PM
Jul-15-21 03:51PM
Jul-14-21 07:56PM
Mar-31-21 04:10PM
Mar-11-21 09:00PM
Mar-09-21 08:15PM
Mar-04-21 05:03PM
Feb-19-21 05:07PM
Feb-16-21 05:30PM
Feb-15-21 03:45PM
Feb-10-21 12:50PM
Feb-08-21 11:07AM
Feb-02-21 08:00AM
Feb-01-21 03:47PM
Jan-28-21 04:30PM
Jan-27-21 02:30PM
Jan-18-21 06:00PM
Jan-14-21 11:45AM
Jan-11-21 05:30PM
Dec-24-20 04:07PM
Dec-23-20 12:40AM
Dec-19-20 11:35PM
Dec-17-20 06:17PM
Dec-16-20 04:47PM
Dec-12-20 08:08PM
Dec-11-20 10:37AM
Dec-10-20 04:10PM
Dec-09-20 11:30PM
Dec-08-20 03:47PM
Dec-07-20 08:13PM
Dec-05-20 09:20PM
Dec-02-20 02:15PM
Dec-01-20 01:15PM
Nov-30-20 09:00PM
Nov-29-20 07:45AM
Nov-27-20 10:17AM
Nov-26-20 01:00PM
Nov-25-20 11:20PM
Nov-24-20 08:47PM
Nov-20-20 04:21PM
Sep-18-20 07:30AM
Sep-17-20 04:05PM
Sep-10-20 07:20AM
Sep-09-20 04:10PM
Aug-14-20 04:59PM
Jul-29-20 07:32AM
Jul-28-20 04:05PM
Jul-10-20 05:00PM
May-30-20 11:59AM
May-29-20 05:08PM
May-28-20 04:30PM
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens, as well as antibiotic-resistant strains that slow the natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Ocucyn eyelid and eyelash cleanser; Gramaderm for the treatment of topical mild to moderate acne; Nanocyn, a hospital-grade disinfectant; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.